STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 is a small molecule inhibitor that targets the transcription factor STAT3, which plays a crucial role in a variety of cellular processes, including cell proliferation, survival, and differentiation. The chemical name of STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 is 4-(4-hydroxyphenyl)-2-thiourea.
The molecular formula of STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 is C7H8N2OS, and its formula weight is 180.22 g/mol. The CAS number of STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 is 501919-59-1.
Top 10 Keywords and Synonyms
Health Benefits of STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859
STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 has been studied for its potential in treating cancer, inflammation, and autoimmune diseases. STAT3 is known to be involved in the development and progression of many types of cancer, and inhibition of STAT3 has been identified as a potential therapeutic strategy.
Potential Effects of STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859
STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 works by blocking the function of STAT3, a transcription factor that is involved in the regulation of cellular processes such as cell proliferation, survival, and differentiation. By inhibiting STAT3, STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 may be able to slow or stop the growth of cancer cells and reduce inflammation in autoimmune diseases.
Product Mechanism
STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 targets the SH2 domain of STAT3, which is essential for the dimerization and activation of the transcription factor. By binding to the SH2 domain, STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 prevents STAT3 from binding to DNA and activating downstream genes. This ultimately leads to inhibition of cell proliferation, survival, and differentiation.
Safety and Side Effects
The safety of STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 has been studied in preclinical models, and the drug has been found to be generally well-tolerated. However, as with any medication, there is a potential for side effects. Common side effects of STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 include nausea, vomiting, and fatigue.
Dosing Information
The dosing of STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 may vary depending on the indication being treated and the patient's individual characteristics. In preclinical studies, doses of STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 ranged from 10 μM to 50 μM.
Patients should always follow the dosing instructions provided by their healthcare provider and report any side effects or concerns promptly.
Conclusion
In conclusion, STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 is a small molecule inhibitor that targets the transcription factor STAT3, a crucial regulator of cell proliferation, survival, and differentiation. The drug has been studied for its potential in treating cancer, inflammation, and autoimmune diseases, and has shown promising results in preclinical studies. While further research is needed to fully understand the safety and efficacy of STAT3 Inhibitor VI S3I-201 NSC74859 NSC-74859 in humans, the initial results are encouraging and suggest that the drug may be a valuable addition to the treatment options available for these diseases. As with any medication, patients should always follow their doctor's instructions and report any side effects or concerns promptly.
